# Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line Therapy

> **NCT01537055** · PHASE4 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 600 (estimated)

## Conditions studied

- Eradication Rate for Helicobacter

## Interventions

- **DRUG:** levofloxacin-based sequential therapy
- **DRUG:** levofloxacin-based triple therapy for 10 days

## Key facts

- **NCT ID:** NCT01537055
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2015-12
- **Final completion:** 2016-04
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2015-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01537055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01537055, "Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line Therapy". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01537055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*